Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-11 Sale |
2024-04-12 4:05 pm |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER |
54 | $6.74 | $364 | 70,849 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:06 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
19,122 | $8.7039 | $166,435 | 710,600 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:05 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D |
4,764 | $8.7101 | $41,495 | 145,720 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:05 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
2,820 | $8.5312 | $24,058 | 77,017 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:05 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY |
4,764 | $8.7102 | $41,495 | 141,270 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:05 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
4,195 | $8.5313 | $35,789 | 164,503 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:05 pm |
Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER |
2,174 | $8.5311 | $18,547 | 149,074 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:05 pm |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER |
3,818 | $8.5313 | $32,573 | 135,903 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:10 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY |
2,062 | $8.96 | $18,476 | 56,034 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:10 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
7,873 | $8.96 | $70,542 | 234,722 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:10 pm |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER |
853 | $9.0684 | $7,735 | 49,721 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:10 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D |
2,062 | $8.96 | $18,476 | 60,484 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:10 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
910 | $9.0684 | $8,252 | 41,337 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:10 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
1,559 | $9.0684 | $14,138 | 78,698 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 4:11 pm |
Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer |
2,509 | $9.4251 | $23,648 | 35,248 (Direct) |
View |
| 2023-10-03 Sale |
2023-10-04 4:05 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
3,091 | $8.2511 | $25,504 | 80,257 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-05 8:15 pm |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer |
457 | $14.71 | $6,723 | 50,574 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-05 8:13 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
1,815 | $14.71 | $26,699 | 61,173 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-05 8:12 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
1,815 | $14.71 | $26,699 | 58,096 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-05 8:10 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
4,455 | $14.71 | $65,533 | 242,595 (Direct) |
View |
| 2023-05-10 Sale |
2023-05-12 4:14 pm |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer |
455 | $16.59 | $7,548 | 51,031 (Direct) |
View |
| 2023-05-10 Sale |
2023-05-12 4:11 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
825 | $16.59 | $13,687 | 56,611 (Direct) |
View |
| 2023-05-10 Sale |
2023-05-12 4:09 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
825 | $16.59 | $13,687 | 59,211 (Direct) |
View |
| 2023-05-10 Sale |
2023-05-12 4:06 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
558 | $16.49 | $9,200 | 42,247 (Direct) |
View |
| 2023-04-11 Sale |
2023-04-13 4:07 pm |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer |
47 | $21.49 | $1,010 | 51,486 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-02 7:11 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
2,590 | $22.25 | $57,628 | 118,686 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-02 7:08 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
2,590 | $22.25 | $57,628 | 121,286 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-08 Option Award |
2024-05-10 4:05 pm |
2025-05-08 2034-05-07 |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
26,000 | $0 | 70,500 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 4:05 pm |
2025-05-08 2034-05-07 |
Travere Therapeutics Inc. | TVTX | COUGHLIN TIMOTHY Director |
26,000 | $0 | 68,500 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 4:05 pm |
2025-05-08 2034-05-07 |
Travere Therapeutics Inc. | TVTX | Bruhn Suzanne Louise Director |
26,000 | $0 | 41,750 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 4:05 pm |
2025-05-08 2034-05-07 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
26,000 | $0 | 50,500 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:06 pm |
N/A 2034-01-30 |
Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER |
495,000 | $0 | 710,600 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-30 |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D |
90,000 | $0 | 145,720 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-30 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
38,500 | $0 | 77,017 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-30 |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY |
90,000 | $0 | 141,270 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-30 |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
90,000 | $0 | 164,503 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-30 |
Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER |
116,000 | $0 | 149,074 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-30 |
Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER |
90,000 | $0 | 135,903 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-05 8:13 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
3,300 | $0 | 61,173 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-05 8:12 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
3,300 | $0 | 58,096 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-05 8:10 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
9,900 | $0 | 242,595 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:06 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
18,000 | $0 | 38,000 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:06 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | Poole Sandra Director |
18,000 | $0 | 30,500 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:05 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | COUGHLIN TIMOTHY Director |
18,000 | $0 | 56,000 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:05 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | Williams Brinkley Ruth Director |
18,000 | $0 | 26,250 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:05 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
18,000 | $0 | 88,000 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:05 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | Orwin John A Director |
18,000 | $0 | 35,875 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:05 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
18,000 | $0 | 58,000 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:05 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | Bruhn Suzanne Louise Director |
18,000 | $0 | 29,250 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:05 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | Squarer Ron Director |
18,000 | $0 | 35,875 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 7:11 pm |
N/A 2033-01-30 |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
81,500 | $0 | 118,686 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 7:08 pm |
N/A 2033-01-30 |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
81,500 | $0 | 121,286 (Direct) |
View |